Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Combination, Palbociclib + Binimetinib
Sponsor: Fundacion Oncosur
Collaborators: Pfizer|Apices Soluciones S.L.|Pierre Fabre Ibérica, S.A.